The SLAMF1 gene gives certain immune cells a surface protein, also called CD150, that helps them communicate and organize the body’s response to infection. If it does not work properly, immune signaling may be less coordinated, which can affect inflammation control and how some infections are handled. In medicine, this gene is important because the measles virus can use the SLAMF1 protein to enter some immune cells. SLAMF1 is better known in research and infectious disease medicine than in everyday public health conversations.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or for regulating activities in the body. Some genes provide the code for proteins, which do much of the cell’s work. Others mainly direct when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medicines. To explore this topic in more detail, you can visit the LearnHub.
Overview
SLAMF1Gene function
What if the gene works
The SLAMF1 gene helps immune cells recognize and communicate with each other. This supports controlled immune responses and can help the body fight infections.
Risk
What if the gene does not work
Different variants in the SLAMF1 gene can have mild to stronger effects. When it works less well, immune cells may communicate less effectively and respond less smoothly to signals from nearby cells.
Treatment
What does that mean for your treatment
No SLAMF1-specific treatment or drug selection approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the SLAMF1 gene. The SLAMF1 gene is being studied mainly as an immune marker and possible research target in some blood cancers, but this has not changed routine treatment.
Gene function
What if the gene works
Your immune cells need clear signals to work together every day. The SLAMF1 gene helps make a surface protein that supports how immune cells communicate with each other. It is mainly active in white blood cells and helps guide normal immune responses.
Its protein sits on the surface of several white blood cells and can attach to the same protein on a nearby immune cell. This direct contact helps immune cells communicate during a normal immune response.
Signals from this protein help strengthen activation after immune cells recognize a target. This supports a more organized response from T cells, B cells, and some other white blood cells.
The SLAMF1 gene helps adjust messages passed between immune cells. This supports teamwork across the immune system, so cells can respond in a coordinated way instead of acting alone.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply reflect natural genetic variation. Sometimes, however, a variant changes gene function more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLAMF1 gene can change the receptor’s shape, stability, or placement on the cell surface, which helps explain how SLAMF1 gene variants affect protein function. Milder variants may only reduce how strongly the protein binds its partners or passes signals inside immune cells. More severe variants can shorten the protein, keep it from reaching the cell surface, or stop key signaling steps altogether.
How variants are linked to conditions
Variants in the SLAMF1 gene do not yet have a broadly confirmed link to a specific health condition, although research on SLAMF1 gene variants and disease risk is still developing. If you have a confirmed change in this gene, your doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors are involved. In some situations, however, a single well-characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLAMF1 gene. If a SLAMF1 change is found on testing, its meaning often depends on the exact change and the larger clinical picture, including personal and family history. Anyone with concerns about personal risk should speak with a doctor or genetic counselor.
Inheritance of SLAMF1 variants
There is not yet a broadly confirmed Mendelian pattern for SLAMF1 gene inheritance tied to a specific SLAMF1 related condition, and this picture may become clearer as research develops. The SLAMF1 gene is located on chromosome 1, which is an autosome, so you inherit one copy from each parent. That means any SLAMF1 gene variant can be passed down through either side of the family.
What does my SLAMF1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for the SLAMF1 gene, though this understanding can change as research develops. If you have a specific SLAMF1 result and questions about what it could mean for your family, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for SLAMF1 variants usually examines the SLAMF1 gene in a blood or saliva sample to look for DNA changes. A lab reads the gene’s sequence and compares it with a standard reference, then classifies any variant as benign, likely benign, uncertain, likely pathogenic, or pathogenic based on current medical evidence.
When should I consider getting a genetic test?
There is not yet a broadly established, SLAMF1-specific reason for genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your symptoms and family history.
A genetic result is only one part of your health story
Genetic findings can be informative, but what they reveal depends on the condition being evaluated and on the specific type of variant involved. How the body works over time is also shaped by factors such as age, lifestyle, environment, and medical history. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result can provide a clear answer. In areas like medication response, it can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This happens because the body can absorb, break down, transport, or react to a drug a little differently from one person to another. These differences are common and can influence how well a treatment works or how likely someone is to notice side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medications. It studies gene-drug patterns to help explain why the same treatment can work differently in different people. With many medicines, genes influence either how strongly a drug works or how the body handles it. This information can support treatment choices that are better informed and more individualized. More detail on this subject is available in the LearnHub.
Drugs influenced by the SLAMF1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general concerns about medicines, side effects, or treatment response are best discussed with your doctor. Seek medical advice if a treatment is not working as expected, causes bothersome side effects, or if new symptoms start after a medicine change.
History
The SLAMF1 gene entered the scientific literature in the late 1990s, when researchers studying immune cell surface proteins identified signaling lymphocytic activation molecule, also called CD150. Initially understood only through visible traits, later recognized as tied to a specific gene, it became part of a newly defined family of related immune genes. Soon after, studies showing that CD150 could act as a receptor for measles virus brought wider research attention to the SLAMF1 gene. From these first observations, research expanded steadily into immunology, infectious disease, and blood cell signaling. Over time, descriptions became more precise as the SLAM family was mapped and renamed in a more systematic way. These historical steps shaped today’s understanding of the SLAMF1 gene.